Steven Patrick Hall

Address:

1016 Pasture Vw Ln, Raleigh, NC 27603

Phone:

9198544682

VIN:

1G1AL15F477256974

Make:

CHEVROLET

Model:

COBALT

Year:

2007

US Patent:

7371852, May 13, 2008

Filed:

Jan 21, 2004

Appl. No.:

10/762078

Inventors:

Klass P. Hardeman - Chapel Hill NC, US
Steven E. Hall - Chapel Hill NC, US
Roy W. Ware - Raleigh NC, US
Lindsay A. Hinkley - Raleigh NC, US
Matthew G. Jenks - Durham NC, US

Assignee:

Serenex, Inc. - Durham NC

International Classification:

C07H 21/00
G01N 33/566
G01N 33/543

US Classification:

536 253, 536 2533, 536 2622, 536 2623, 536 2626, 536 267, 536 268, 436501, 436518

Abstract:

Alkyl-linked nucleotide non-homogeneous solid supports and nucleotide affinity media comprising an alkyl-linked nucleotide are provided. The linker is generally a hydrophobic linker that can be a 3, 4, 5, 6, 7, 8, 9, 10, or a longer carbon chain. Also included in the invention are methods for synthesis of an alkyl-linked nucleotide, nucleotide affinity media and methods of use thereof for affinity chromatography and screening methods.

US Patent:

20070207984, Sep 6, 2007

Filed:

Feb 26, 2007

Appl. No.:

11/678975

Inventors:

Kenneth Huang - Chapel Hill NC, US
Jeron Eaves - Chapel Hill NC, US
James Veal - Apex NC, US
Steven Hall - Chapel Hill NC, US
Thomas Barta - Carrboro NC, US
Gunnar Hanson - Dallas TX, US

International Classification:

A61K 31/675
C07D 231/56
C07D 209/02
A61K 31/405

US Classification:

514080000, 514406000, 514415000, 548113000, 548361100, 514414000, 548465000, 548469000

Abstract:

Disclosed are compounds and pharmaceutically acceptable salts of Formula (I), wherein Q, Q, R, R, R, R, R, R, R, X, X, X, and Y are as defined herein. Compounds of Formula (I) are useful in the treatment of diseases and/or conditions related to cell proliferation, such as cancer, inflammation, arthritis, angiogenesis, or the like. Also disclosed are pharmaceutical compositions comprising compounds of the invention and methods of treating the aforementioned conditions using such compounds.

US Patent:

20080076800, Mar 27, 2008

Filed:

Aug 24, 2007

Appl. No.:

11/844629

Inventors:

Kenneth Huang - Chapel Hill NC, US
Thomas Barta - Carrboro NC, US
Emilie Smith - Apex NC, US
Steven Hall - Chapel Hill NC, US
James Veal - Apex NC, US

International Classification:

A61K 31/44
A61K 31/166
A61K 31/196
A61K 31/216
A61K 31/443
A61P 19/02
A61P 29/00
A61P 35/00
A61P 9/00
C07D 405/12
C07D 335/02
C07D 309/14
C07D 213/85
C07D 213/82
C07D 211/58
C07C 255/58
C07C 233/65
C07C 229/42
A61P 37/00
A61P 31/00
A61P 25/00
A61K 31/4465
A61K 31/277
A61K 31/351
A61K 31/382

US Classification:

514329000, 514336000, 514344000, 514432000, 514459000, 514539000, 514567000, 514618000, 514619000, 514646000, 546223000, 546284700, 546289000, 546297000, 549028000, 549424000, 558418000, 560043000, 562441000, 564162000, 564167000

Abstract:

Disclosed are compounds and pharmaceutically acceptable salts of Formula I wherein A, Q, Q, Q, R, R, R, R, m, and p are as defined herein. Compounds of Formula I are useful in the treatment of diseases and/or conditions related to cell proliferation, such as cancer, inflammation, arthritis, angiogenesis, or the like. Also disclosed are pharmaceutical compositions comprising compounds of the invention and methods of treating the aforementioned conditions using such compounds.

US Patent:

20080119457, May 22, 2008

Filed:

Aug 24, 2007

Appl. No.:

11/844816

Inventors:

Kenneth He Huang - Chapel Hill NC, US
John Mangette - Clifton Park NY, US
Thomas Barta - Carrboro NC, US
Steven E. Hall - Chapel Hill NC, US
James Veal - Apex NC, US
Philip Hughes - Chapel Hill NC, US

International Classification:

A61K 31/55
A61K 31/551
A61K 31/5377
A61K 31/506
A61K 31/496
A61K 31/501
C07D 413/02
C07D 403/02

US Classification:

51421704, 51421705, 5142355, 514218, 51425202, 51425214, 51425301, 544122, 544295, 544360, 540575, 540597, 540600

Abstract:

Disclosed are compounds and pharmaceutically acceptable salts of Formula Iwherein A, Q, Q, Q, R, and Rare as defined herein. Compounds of Formula I are useful in the treatment of diseases and/or conditions related to cell proliferation, such as cancer, inflammation, arthritis, angiogenesis, or the like. Also disclosed are pharmaceutical compositions comprising compounds of the invention and methods of treating the aforementioned conditions using such compounds.

US Patent:

20090093452, Apr 9, 2009

Filed:

Aug 24, 2007

Appl. No.:

11/844764

Inventors:

Kenneth He Huang - Chapel Hill NC, US
Steven E. Hall - Chapel Hill NC, US
James Veal - Apex NC, US

International Classification:

A61K 31/5377
C07D 409/04
A61K 31/416
A61P 35/00
A61K 31/403
C07D 413/14
C07D 413/04
A61K 31/422
A61K 31/427
C07D 417/04

US Classification:

51421018, 5483601, 514406, 514414, 548527, 548234, 514377, 514370, 548194, 544111

Abstract:

Disclosed are compounds and pharmaceutically acceptable salts of Formula Iwherein R, R, n, Q, Q, Y, and X-Xare as defined herein. Compounds of Formula I are useful in the treatment of diseases and/or conditions related to cell proliferation, such as cancer, inflammation, arthritis, angiogenesis, or the like. Also disclosed are pharmaceutical compositions comprising compounds of the invention and methods of treating the aforementioned conditions using such compounds.

US Patent:

20180071948, Mar 15, 2018

Filed:

Sep 13, 2016

Appl. No.:

15/264384

Inventors:

Matthew Dwain Campbell - Austin TX, US
Tyler Ray Ortego - Metairie LA, US
Robert Leon Beine - Lancaster KY, US
Steven G. Hall - Raleigh NC, US

International Classification:

B28B 1/00
B33Y 10/00
B33Y 70/00
B33Y 30/00

Abstract:

Methods and equipment are disclosed relating to three-dimensional printing that include positioning an array of nozzles within a bed of loose solid material, moving the array of nozzles through the bed of loose solid material while injecting a liquid from the array of nozzles in a controlled pattern causing the liquid to react with a portion of the bed of loose solid material forming a solid concrete three-dimensional object. An unreacted portion of the bed of loose solid material may then be separated from the solid three-dimensional object.

US Patent:

20150329493, Nov 19, 2015

Filed:

May 19, 2015

Appl. No.:

14/716002

Inventors:

Steven E. Hall - Chapel Hill NC, US

International Classification:

C07D 231/56
C07D 401/12
C07D 405/12
C07D 209/08
C07D 403/12

Abstract:

Disclosed are compounds and pharmaceutically acceptable salts of Formula Iwherein R, R, R, R, R, R, R, n, Q, Q, Q, Y, and X-Xare as defined herein. Compounds of Formula I are useful in the treatment of diseases and/or conditions related to cell proliferation, such as cancer, inflammation, arthritis, angiogenesis, or the like. Also disclosed are pharmaceutical compositions comprising compounds of the invention and methods of treating the aforementioned conditions using such compounds.